1 Key barriers to multiple myeloma clinical trial participation were identified, and country-specific recommendations are provided. 2 Findings will advance the field and can form the basis of a framework that informs the optimal implementation of recommendations. Therapies for multiple myeloma (MM) ...
No comments yet
Be the first to share your thoughts!